A relationship between serum gentamicin concentrations and minimal inhibitory concentration

Drugs under Experimental and Clinical Research

Volumn 22, Issue 2, 1996, Pages 57-60

  Bezirtzoglou, E ^a   Golegou, S ^b   Savvaidis, I ^a   Bezirtzoglou, C ^c   Beris, A ^a   Xenakis, T ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^c Statistical Computer Analysis   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GENTAMICIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIOSTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; FLUORESCENCE POLARIZATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION; MINIMUM INHIBITORY CONCENTRATION; PRACTICE GUIDELINE;

ANTI-BACTERIAL AGENTS; CREATININE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GENTAMICINS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MICROBIAL SENSITIVITY TESTS;

EID: 0029790655     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Stewart C., Evans W.E. The effect of disease on pharmacokinetics: an overview. Ther. Drug Monit., 3, 1-7, 1981.
2. Jolley M.E. et al. Monitoring aminoglycoside antibiotics in serum and plasma. Clin. Chem., 27, 1190-1197, 1981.
3. Yee G.C., Evans W.E. Reappraisal of guidelines for pharmacokinetic monitoring of aminoglycosides. Pharmacotherapy, 1, 55-75, 1981.
4. Jolley M.E. Fluorescence polarization immunoassay for the determination of therapeutic drug levels in human plasma. J. Anal. Toxicol., 5, 236-240, 1981.
5. Van Scoy R.E., Wilson W.R. Antimicrobial agents in patients with renal insufficiency. Mayo Clin. Proc., 58, 246-248, 1983.
6. Zaske D.E., Cipolle R.J., Strate R.G. Gentamicin dosage requirements; wide interpatient variations in 242 surgery patients with normal renal function. Surgery, 98, 164-169, 1980.
7. Christensen M.L., Stewart C.F., Crom W.R. Evaluation of aminoglycoside disposition in patients previously treated with cisplatin. Ther. Drug Monit., 11, 631-636, 1989.
8. Schentag J.J. The significance of the relationship between tissue serum ratios, tissue concentrations and the location of microorganisms. Research and Clinical Forums. 12, 23-27, 1990.
9. Schumacher G.E. Pharmacokinetic and microbiologic evaluation of antibiotic dosage regimens. Clin. Pharm., 1, 66-75, 1982.
10. Hamilton S.F., Evans W.E. Accuracy of using pre- and postdose gentamicin serum concentrations to estimate pharmacokinetic parameters and adjust doses in children and adolescents. Ther. Drug Monit., 3, 57-61, 1981.